The store will not work correctly when cookies are disabled.
2,4-Dichloro-N-(1-(pyridin-2-ylmethyl)piperidin-4-yl)benzamide
ID: ALA4069761
PubChem CID: 47058964
Max Phase: Preclinical
Molecular Formula: C18H19Cl2N3O
Molecular Weight: 364.28
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NC1CCN(Cc2ccccn2)CC1)c1ccc(Cl)cc1Cl
Standard InChI: InChI=1S/C18H19Cl2N3O/c19-13-4-5-16(17(20)11-13)18(24)22-14-6-9-23(10-7-14)12-15-3-1-2-8-21-15/h1-5,8,11,14H,6-7,9-10,12H2,(H,22,24)
Standard InChI Key: HAUZEROVTILWJN-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
1.5069 -2.9499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5058 -3.7774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2205 -4.1902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9370 -3.7769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9342 -2.9463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2188 -2.5372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2163 -1.7122 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.7910 -4.1893 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.6470 -2.5312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3631 -2.9410 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6440 -1.7062 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0760 -2.5257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7906 -2.9383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5015 -2.5266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5026 -1.7013 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7867 -1.2893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0697 -1.7026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2171 -1.2888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9315 -1.7013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9265 -2.5261 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6400 -2.9385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3555 -2.5260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3529 -1.6967 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6387 -1.2880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
2 8 1 0
5 9 1 0
9 10 1 0
9 11 2 0
10 12 1 0
12 13 1 0
12 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
15 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.28 | Molecular Weight (Monoisotopic): 363.0905 | AlogP: 3.78 | #Rotatable Bonds: 4 |
Polar Surface Area: 45.23 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.53 | CX Basic pKa: 7.61 | CX LogP: 2.87 | CX LogD: 2.45 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.90 | Np Likeness Score: -2.27 |
References
1. Jørgensen L, Al-Khawaja A, Kickinger S, Vogensen SB, Skovgaard-Petersen J, Rosenthal E, Borkar N, Löffler R, Madsen KK, Bräuner-Osborne H, Schousboe A, Ecker GF, Wellendorph P, Clausen RP.. (2017) Structure-Activity Relationship, Pharmacological Characterization, and Molecular Modeling of Noncompetitive Inhibitors of the Betaine/γ-Aminobutyric Acid Transporter 1 (BGT1)., 60 (21): [PMID:28991462] [10.1021/acs.jmedchem.7b00924] |